Dark Matter Therapeutics Inc. Inc
AI-driven phenotype-based discovery for more effective drugs in complex unmet medical conditions
Ce qui nous motive
Mission
Alter the Drug discovery paradigm from a target-centric one to an AI-driven phenotype based one.
Équipe
Membres de l'équipe
Steven Zimmer-co-founder and acting CEO Prof Lei Xie-Scientific Founder and acting CSO Yoyo Wu-AI Scientist-PhD student (April 2025)
Sur Foundersbase
Voir Dark Matter Therapeutics Inc. le profil complet de la société pour
- Identifier le potentiel de collaboration ou devenir membre de l'équipe
- En savoir plus sur "Dark Matter Therapeutics Inc. la vision et les offres de l'entreprise
- Se connecter et contacter "Dark Matter Therapeutics Inc. les fondateurs directement
Les gens ont aussi regardé
-
ThriftShopper
Market intelligence for recommerce, data-driven + predictive AI
-
aponi.ai
Democratizing employment law with AI while capturing predictive signals for insurance carriers
-
Ez Marketing
We offer service tracking that helps marketing agencies sell services
-
InnerChild
We offer gamified well-being with concept of inner child.